Expert opinion: Adherence to prophylactic migraine medication

Headache

Volumn 49, Issue 7, 2009, Pages 1054-1058

  Evans, Randolph W ^a   Linde, Mattias ^b  

^a University of Gothenburg ^*  (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adherence; Compliance; Migraine; Prevention; Prophylaxis

Indexed keywords

AMITRIPTYLINE; TOPIRAMATE;

ADULT; BEDTIME DOSAGE; CASE REPORT; FEMALE; HUMAN; MEDICATION ADHERENCE REPORT SCALE; MIGRAINE; NOTE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; REINFORCEMENT; SELF REPORT; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; EXPERT TESTIMONY; FEMALE; HUMANS; MEDICATION ADHERENCE; MIGRAINE DISORDERS;

EID: 67651160762     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01471.x     Document Type: Note

References (33)

1. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine - Report of an EFNS task force. Eur J Neurol. 2006 13 : 560 572.
2. Diener H, Kaube H, Limmroth V. A practical guide to the management and prevention of migraine. Drugs. 1998 56 : 811 818.
3. Eraker S, Kirscht J, Becker M. Understanding and improving patient compliance. Ann Intern Med. 1984 100 : 258 268.
4. Steiner T, Catarci T, Hering R, Whitmarsh T, Couturier E. If migraine prophylaxis does not work, think about compliance. Cephalalgia. 1994 14 : 463 464.
5. Aubé M. Improving patient compliance to prophylactic migraine therapy. Can J Neurol Sci. 2002 29 (Suppl. 2 40 43.
6. Nichol M, Venturini F, Sung J. A critical evaluation of the literature on medication compliance. Ann Pharmacother. 1999 33 : 531 540.
7. Haynes R, Yao X, Degani A, Kripalani S, Garg A, McDonald H. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005 4 : CD000011.
8. Rahimtoola H, Buurma H, Tijssen C, Leufkens H, Egberts A. Migraine prophylactic medication usage patterns in the Netherlands. Cephalalgia. 2003 23 : 293 301.
9. Rains J, Lipchick G, Penzien D. Behavioral facilitation of medical treatment for headache - Part I: Review of headache treatment compliance. Headache. 2006 46 : 1387 1394. (Pubitemid 44556429)
10. Mulleners W, Whitmarsh T, Steiner T. Non-compliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia. 1998 18 : 52 56.
11. Linde M, Jonsson P, Hedenrud T. Influence of disease features on adherence to prophylactic migraine medication. Acta Neurol Scand. 2008 118 : 367 372.
12. Hedenrud T, Jonsson P, Linde M. Beliefs about medicines and adherence among Swedish migraineurs. Ann Pharmacother. 2008 42 : 39 45.
13. Peters M, Huijer Abu-Saad H, Vydelingum V, Dowson A, Murphy M. Patients' decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia. 2003 23 : 833 841.
14. Garber M, Nau D, Erickson S, Aikens J, Lawrence J. The concordance of self-report with other measures of medication adherence: A summary of the literature. Med Care. 2004 42 : 649 652.
15. Cline C, Björck-Linné A, Israelsson B, Willenheomer R, Erhardt L. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail. 1999 1 : 145 149. (Pubitemid 30186705)
16. Cramer J, Mattson R. Monitoring compliance with antiepileptic drug therapy. In : Cramer J, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trial. New York : Raven Press 1991 : 123 137.
17. Horne R, Weinman J. Predicting treatment adherence: An overview of theoretical models. In : Myers L, Midence K, eds. Adherence to Treatment in Medical Conditions. London : Harwood Academic 1998 : 25 50.
18. George J, Kong D, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005 128 : 3198 3204.
19. Horne R, Weinman J. Self-regulation and self-management in asthma: Exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002 17 : 17 32.
20. Byrne M, Walsh J, Murphy A. Secondary prevention of coronary heart disease: Patient beliefs and health-related behaviour. J Psychosom Res. 2005 58 : 403 415.
21. Massiou H. Migraine medication attributes are important for patient compliance. Drugs Today. 2003 39 (Suppl. D 25 29.
22. O'Carroll R, McGregor L, Swanson V, Masterton G, Hayes P. Adherence to medication after liver transplantation in Scotland: A pilot study. Liver Transpl Surg. 2006 12 : 1862 1868.
23. Misdrahi D, Llorca P, Lançon C, Bayle F. Compliance in schizophrenia: Predictive factors, therapeutical considerations and research implications. Encephale. 2002 28 : 266 272.
24. Gallagher R, Kunkel R. Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment. Headache. 2003 43 : 36 43.
25. Claxton A, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001 23 : 1296 1310.
26. MacGregor E. The doctor and the migraine patient: Improving compliance. Neurology. 1997 48 (Suppl. 3 16 20.
27. Goadsby P. The scientific basis of medication choice in symptomatic migraine treatment. Can J Neurol Sci. 1999 26 (Suppl. 3 20 26.
28. Miller W, Rollnick S. Motivational Interviewing: Preparing People for Change, 2nd edn. New York : The Guilford Press 2002.
29. Baskin S. Managing the "difficult" headache patient. Neurol Sci. 2007 28 : S78 S83.
30. Rains J, Penzien D, Lipchick G. Behavioral facilitation of medical treatment for headache - Part II: Theoretical models and behavioral strategies for improving adherence. Headache. 2006 46 : 1395 1403. (Pubitemid 44556430)
31. Linde M. Migraine: A review and future directions for treatment. Acta Neurol Scand. 2006 114 : 71 83.
32. Varkey E, Cider A, Carlsson J, Linde M. A study to evaluate the feasibility of an aerobic exercise program in patients with migraine. Headache. 2009 49 : 563 570.
33. Buse D, Andrasik F. Behavioral medicine for migraine. Neurol Clin. 2009 27 : 445 465.